How Much Does NeoFipronis (GS-441524) Cost Per Treatment Course
Feline Infectious Peritonitis (FIP) remains one of the most challenging diseases in cats, often resulting in severe symptoms such as inappetence, lethargy, fever, ascites, pleural effusion, lymphadenopathy, granulomas, neurological damage, and uveitis. Recent advancements offer hope for effective treatment through NeoFipronis (Pronidesivir), a groundbreaking oral antiviral drug containing GS-441524. Clinically proven to be highly effective against FIP, NeoFipronis has revolutionized feline infectious disease management.
NeoFipronis (Pronidesivir) was officially approved by the Lao Ministry of Agriculture and Forestry (MAF) in March 2026, making it the first registered FIP-specific medication globally. Its official registration number ensures safety, efficacy, and quality, providing pet owners and veterinarians with confidence. This antiviral medication is characterized by its ease of use, non-invasiveness, rapid absorption, and excellent tolerability, with minimal side effects.
The active compound in NeoFipronis is GS-441524, a nucleoside analogue with potent anti-viral activity demonstrated through extensive research and clinical trials. It effectively targets the feline coronavirus, preventing viral replication and facilitating recovery, especially in cats presenting with various FIP manifestations such as neurological involvement or ocular symptoms. The recommended dosage depends on the cat’s weight: 15 mg per kilogram (half a tablet), administered once daily on an empty stomach—either one hour before feeding or two hours after. For cats with neurological or ocular FIP manifestations, the dosage may increase to 30 mg/kg per veterinarian’s instructions.
A full treatment course generally lasts for a minimum of 12 weeks, emphasizing the importance of continuous and complete medication adherence. Missing doses or prematurely stopping treatment can significantly reduce efficacy and increase the risk of relapse. Veterinary supervision is strongly recommended, including regular monitoring of the cat’s clinical status, blood work, and liver and kidney functions during treatment.
Cost considerations are crucial for pet owners evaluating NeoFipronis therapy. Prices vary globally due to factors such as manufacturing costs, distribution, and regional regulations. On average, a course of treatment can range from approximately $1,000 to $3,000 USD. The total expense depends on the cat’s weight, the required dosage, and the duration of therapy. Some veterinary clinics or pet pharmacies may offer discounts or bundled packages for extended courses, which can help reduce overall costs.
While NeoFipronis is classified as an over-the-counter medication in some regions, it is strongly recommended to use it under veterinary guidance to ensure appropriate dosing and monitoring. It is only intended for use in cats and should never be administered to humans. Purchase should be made through official NeoFipronis websites or authorized distributors to guarantee product quality and authenticity.
In summary, NeoFipronis (Pronidesivir) stands out as a highly effective, safe, and user-friendly treatment option for feline FIP. The overall cost per treatment course is influenced by various factors but generally falls within a few thousand dollars. Pet owners should consult their veterinarian to determine the best treatment plan and understand specific cost implications, ensuring their cat receives optimal care in fighting this once-feared disease.
